Serum protein profile alterations in hemodialysis patients

被引:20
作者
Langlois, RG
Trebes, JE
Dalmasso, EA
Ying, Y
Davies, RW
Curzi, MP
Colston, BW
Turteltaub, KW
Perkins, J
Chromy, BA
Choi, MW
Murphy, GA
Fitch, JP
McCutcheon-Maloney, SL
机构
[1] Lawrence Livermore Natl Lab, Biodef Div, Livermore, CA 94550 USA
[2] Ciphergen Biosyst, Fremont, CA USA
[3] Diablo Nephrol Med Grp Inc, Walnut Creek, CA USA
关键词
hemodialysis; SELDI-TOF-MS; protein profiling; proteomics; biomarkers;
D O I
10.1159/000077409
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Serum protein profiling patterns can reflect the pathological state of a patient and therefore may be useful for clinical diagnostics. Here, we present results from a pilot study of proteomic expression patterns in hemodialysis patients designed to evaluate the range of serum proteomic alterations in this population. Methods: Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS) was used to analyze serum obtained from patients on periodic hemodialysis treatment and healthy controls. Serum samples from patients and controls were first fractionated into six eluants on a strong anion exchange column, followed by application to four array chemistries representing cation exchange, anion exchange, metal affinity and hydrophobic surfaces. A total of 144 SELDI-TOF-MS spectra were obtained from each serum sample. Results: The overall profiles of the patient and control samples were consistent and reproducible. However, 30 well-defined protein differences were observed; 15 proteins were elevated and 15 were decreased in patients compared to controls. Serum from 1 patient exhibited novel protein peaks suggesting possible additional changes due to a secondary disease process. Conclusion: SELDI-TOF-MS demonstrated consistent serum protein profile differences between patients and controls. Similarity in protein profiles among dialysis patients suggests that patient physiological responses to end-stage renal disease and/or dialysis therapy have a major effect on serum protein profiles. Copyright (C) 2004 S. Karger AG, Basel.
引用
收藏
页码:268 / 274
页数:7
相关论文
共 24 条
[1]   Impact of dialysis dose and membrane on infection-related hospitalization and death: Results of the HEMO study [J].
Allon, M ;
Depner, TA ;
Radeva, M ;
Bailey, J ;
Beddhu, S ;
Butterly, D ;
Coyne, DW ;
Gassman, JJ ;
Kaufman, AM ;
Kaysen, GA ;
Lewis, JA ;
Schwab, SJ .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (07) :1863-1870
[2]   The human plasma proteome - History, character, and diagnostic prospects [J].
Anderson, NL ;
Anderson, NG .
MOLECULAR & CELLULAR PROTEOMICS, 2002, 1 (11) :845-867
[3]   Inflammatory signals associated with hemodialysis [J].
Caglar, K ;
Peng, Y ;
Pupim, LB ;
Flakoll, PJ ;
Levenhagen, D ;
Hakim, RM ;
Ikizler, TA .
KIDNEY INTERNATIONAL, 2002, 62 (04) :1408-1416
[4]   A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease [J].
Carrette, O ;
Demalte, I ;
Scherl, A ;
Yalkinoglu, O ;
Corthals, G ;
Burkhard, P ;
Hochstrasser, DF ;
Sanchez, JC .
PROTEOMICS, 2003, 3 (08) :1486-1494
[5]  
*CHIPH PROT CHIP, CHIPH PROT CHIP APPL, P107
[6]   Characterization of renal allograft rejection by urinary proteomic analysis [J].
Clarke, W ;
Silverman, BC ;
Zhang, Z ;
Chan, DW ;
Klein, AS ;
Molmenti, EP .
ANNALS OF SURGERY, 2003, 237 (05) :660-664
[7]   Disease proteomics [J].
Hanash, S .
NATURE, 2003, 422 (6928) :226-232
[8]   NEW DESORPTION STRATEGIES FOR THE MASS-SPECTROMETRIC ANALYSIS OF MACROMOLECULES [J].
HUTCHENS, TW ;
YIP, TT .
RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 1993, 7 (07) :576-580
[9]   The SELDI-TOF MS approach to proteomics: Protein profiling and biomarker identification [J].
Issaq, HJ ;
Veenstra, TD ;
Conrads, TP ;
Felschow, D .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 292 (03) :587-592
[10]   SELDI-TOF MS for diagnostic proteomics. [J].
Issaq, HJ ;
Conrads, TP ;
Prieto, DA ;
Tirumalai, R ;
Veenstra, TD .
ANALYTICAL CHEMISTRY, 2003, 75 (07) :148A-155A